A new COVID-19 medication has been approved in Abu Dhabi for the treatment of mild to moderate cases and those who have had direct contact with a patient.
The emirate's Department of Health (DoH) has partnered with Swiss healthcare company Roche to provide casirivimab and imdevimab to certain categories of patients.
The antibody combination has already been approved in the European Union and Japan, and conditionally approved in the UK and Australia.
It is also authorised for emergency use in the United States, India, Switzerland and Canada, and is recommended by the World Health Organisation (WHO).
.@DoHSocial has partnered with Swiss healthcare company @Roche to provide a new Covid-19 medication, approved for emergency use, to treat mild to moderate Covid-19 cases and those who have had direct contact with a positive case.
— مكتب أبوظبي الإعلامي (@ADMediaOffice) December 1, 2021
Read more: https://t.co/vGQXyUvhGB pic.twitter.com/Yj9JxVgemP
H.H. Sheikh Mohammed hails Morocco's 'fighting spirit' in World Cup run
UAE aid convoys enter Gaza with food and shelter supplies
UAE leaders congratulate US President on Independence Day
Dubai private schools to offer life skills to shape future-ready students
Warning issued after 25 injured in 4 vehicle collision on Jebel Ali Road
H.H. Sheikh Mohammed applauds Egypt's 'heroic' World Cup run
UAE calls for immediate Sudan ceasefire, expansion of arms embargo
Dubai community campaign supports workers with 2 million refreshments
